Multicenter Patency Trial of Intravenous Antistreplase Compared With Streptokinase in Acute Myocardial Infarction - TEAM-2

Description:

TEAM-2 was a prospective, randomized, double-blind, placebo-controlled, multicenter trial of antistreplase versus streptokinase in patients with ST-segment elevation myocardial infarction.